Eli Lilly and Co. has said it will settle about 18,000 additional lawsuits alleging the drugmaker did not adequately warn patients that its anti-psychotic medication Zyprexa carries a heightened risk of diabetes.

Lilly did not disclose the amount of the settlement but said in a statement it would take a fourth-quarter settlement charge that’s not expected to exceed $500 million.